4.5 Article

Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 150, Issue -, Pages 57-63

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2019.02.026

Keywords

Metrnl; Glucose tolerance; Impaired endothelial function; Atherosclerosis

Ask authors/readers for more resources

Objective: Meteorin-like (Metrnl) is a novel secreted protein that has a beneficial effect on glucose homeostasis with anti-inflammatory properties. Our goal is to determine whether low serum Metrnl levels are associated with worsening of glucose tolerance, impaired endothelial function, and atherosclerosis. Methods: This study included 260 adults, 89 of whom had normal oral glucose tolerance (nOGT), 77 with glucose tolerance impairment (GTI) and 94 with type 2 diabetes (T2DM). Insulin resistance was assessed by evaluating the homeostasis model assessment of insulin resistance (HOMA-IR). Serum Metrnl level, proinflammatory, biochemical, endothelial and atherosclerosis parameters were measured. Results: Serum Metrnl levels decreased significantly in patients with T2DM versus subjects with nOGT (P < 0.001). Metrnl levels were negatively correlated with fasting blood glucose, 2-h postload glucose (2 h-PLG), fasting insulin, HOMA-IR, HbA1c, high-sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), Carotid intima media thickness (CIMT), brachial-ankle pulse wave velocity (baPWV), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin. High serum Metrnl level was significantly correlated with reduced risk of T2DM as revealed by multivariate logistic regression analysis after control of potential risk factors for diabetes. Furthermore, the association remains significant after further adjustment for IL-6, TNF-alpha, hs-CRP, CIMT, baPWV, ICAM-1, VCAM-1 and E-selectin. Conclusions: Low Serum Metrnl may be associated with worsening of glucose tolerance, impaired endothelial function and atherosclerosis. It may also be considered a possible surrogate marker of endothelial dysfunction, and atherosclerosis and an independent risk factor of T2DM. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Serum cathelicidin as a marker for diabetic nephropathy in patients with type 1 diabetes

Hazem M. El-Ashmawy, Azza M. Ahmed

DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)

Article Gastroenterology & Hepatology

Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes

Hazem M. El-Ashmawy, Azza M. Ahmed

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Endocrinology & Metabolism

Association of serum podocalyxin levels with peripheral arterial disease in patients with type 2 diabetes

Hazem M. EL-Ashmawy, Fayrouz O. Selim, Thoraya A. M. Hosny, Hosam N. Almassry

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)

Article Endocrinology & Metabolism

Proinsulin/insulin ratio as a predictor of insulin resistance in patients with diabetic nephropathy

Fawzy A. F. El-Messallamy, Hazem M. El-Ashmawy, Arafa M. El Shabrawy, Samia E. Radwan

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)

Article Cardiac & Cardiovascular Systems

Serum endostatin level as a marker for coronary artery calcification in type 2 diabetic patients

Hazem M. El-Ashmawy, Hisham S. Roshdy, Zizi Saad, Azza M. Ahmed

JOURNAL OF THE SAUDI HEART ASSOCIATION (2019)

No Data Available